TrialBMC ophthalmology2014

Comparison of 1-year therapeutic effect of ranibizumab and bevacizumab for myopic choroidal neovascularization: a retrospective, multicenter, comparative study.

Dong Min Cha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.